enVVeno Medical Corp SEC filings NVNO
enVVeno Medical Corp has 415 filings in SEC EDGAR's recent list, going back to Dec 15, 2015. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFR14A | Filing | Dec 2, 2025 | — |
| PRER14A | Filing | Nov 19, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 14, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2025 | — |
| EFFECT | Filing | Nov 3, 2023 | — |
| CORRESP | Letter to the SEC | Nov 1, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2023 | — |
| EFFECT | Filing | Aug 23, 2023 | — |
| CORRESP | Letter to the SEC | Aug 21, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| 25-NSE | Delisting notice | May 26, 2023 | — |
| UPLOAD | Letter from the SEC | May 16, 2022 | — |
| CORRESP | Letter to the SEC | May 11, 2022 | — |
| UPLOAD | Letter from the SEC | May 6, 2022 | — |
| EFFECT | Filing | May 6, 2021 | — |
| EFFECT | Filing | Feb 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2020 | — |
| EFFECT | Filing | Nov 30, 2020 | — |
| CORRESP | Letter to the SEC | Nov 27, 2020 | — |
| NT 10-Q | Filing | Nov 17, 2020 | Sep 30, 2020 |
| UPLOAD | Letter from the SEC | Nov 12, 2020 | — |
| EFFECT | Filing | Oct 22, 2020 | — |
| CORRESP | Letter to the SEC | Oct 20, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2020 | — |
| CORRESP | Letter to the SEC | Aug 10, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2020 | — |
| D | Filing | Aug 4, 2020 | — |
| EFFECT | Filing | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 15, 2020 | — |
| CORRESP | Letter to the SEC | Jul 15, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| EFFECT | Filing | Jun 23, 2020 | — |
| CORRESP | Letter to the SEC | Jun 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2020 | — |
| EFFECT | Filing | Apr 16, 2020 | — |
| CORRESP | Letter to the SEC | Apr 15, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2020 | — |
| D | Filing | Mar 10, 2020 | — |
| EFFECT | Filing | Jun 11, 2019 | — |
| CORRESP | Letter to the SEC | Jun 10, 2019 | — |
| UPLOAD | Letter from the SEC | May 28, 2019 | — |
| UPLOAD | Letter from the SEC | May 21, 2019 | — |
| DRS | Filing | May 15, 2019 | — |
| EFFECT | Filing | May 6, 2019 | — |
| D/A | Filing | May 3, 2019 | — |
| EFFECT | Filing | Apr 29, 2019 | — |
| CORRESP | Letter to the SEC | Apr 25, 2019 | — |
| D | Filing | Apr 16, 2019 | — |
| EFFECT | Filing | Jun 20, 2018 | — |
| CORRESP | Letter to the SEC | Jun 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2018 | — |
| EFFECT | Filing | May 30, 2018 | — |
| CERT | Filing | May 30, 2018 | — |
| 8-A12B/A | Filing | May 25, 2018 | — |
| CORRESP | Letter to the SEC | May 25, 2018 | — |
| CORRESP | Letter to the SEC | May 25, 2018 | — |
| CORRESP | Letter to the SEC | Feb 8, 2018 | — |
| CORRESP | Letter to the SEC | Dec 18, 2017 | — |
| CORRESP | Letter to the SEC | Dec 18, 2017 | — |
| CORRESP | Letter to the SEC | Dec 14, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2017 | — |
| 8-A12B | Filing | Dec 12, 2017 | — |
| CORRESP | Letter to the SEC | Dec 5, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2017 | — |
| CORRESP | Letter to the SEC | Nov 3, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2017 | — |
| CORRESP | Letter to the SEC | Sep 6, 2017 | — |
| D | Filing | Jun 26, 2017 | — |
| D | Filing | Mar 22, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2017 | — |
| DRS | Filing | Feb 13, 2017 | — |
| D | Filing | Dec 15, 2015 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NVNO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661053
- Former names
- Hancock Jaffe Laboratories, Inc. (until Sep 22, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.